- Home
- ARCT vs ATRO Comparison
ARCT vs ATRO Comparison
Compare ARCT & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARCT | ATRO |
|---|---|---|
| Founded | 2013 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 1.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | ATRO |
|---|---|---|
| Price | $6.40 | $52.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | $38.67 | ★ $61.50 |
| AVG Volume (30 Days) | ★ 820.7K | 560.4K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $97,601,000.00 | ★ $830,601,000.00 |
| Revenue This Year | N/A | $9.26 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.19 |
| 52 Week Low | $5.85 | $15.41 |
| 52 Week High | $24.17 | $55.65 |
Technical Indicators
Market Signals| Indicator | ARCT | ATRO |
|---|---|---|
| Relative Strength Index (RSI) | 34.96 | 52.41 |
| Support Level | $7.04 | $50.01 |
| Resistance Level | $7.76 | $53.78 |
| Average True Range (ATR) | 0.44 | 2.44 |
| MACD | 0.24 | -0.27 |
| Stochastic Oscillator | 23.98 | 41.53 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.